Status:
RECRUITING
5-Day Preoperative Radiation for Soft Tissue Sarcoma
Lead Sponsor:
Stanford University
Conditions:
Soft Tissue Sarcoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to examine the safety and efficacy of an abbreviated course of preoperative radiation, given over five days, for patients with soft tissue sarcoma of the extremity, trunk ...
Eligibility Criteria
Inclusion
- Histologically confirmed soft tissue sarcoma of the extremity, trunk or retroperitoneum.
- Has been offered preoperative radiation and surgery as part of standard-of-care treatment
- Age ≥ 18
- KPS ≥ 70 or ECOG 0 to 2
- Life expectancy ≥ 6 months
- If a woman is of childbearing potential, a negative serum or urine pregnancy test must be documented.
- Ability to understand and the willingness to personally sign the written IRB approved informed consent document.
Exclusion
- History of prior radiation to the area to be treated.
- Active use of other anti-cancer investigational agents.
- Planned use of concurrent chemotherapy, targeted therapy, or immunotherapy with radiation therapy (defined as the time interval starting 1 week before the first and last fraction of radiation therapy and surgery).
- Pregnancy.
Key Trial Info
Start Date :
October 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06087861
Start Date
October 6 2023
End Date
January 1 2026
Last Update
July 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305